The Medical Advisor

Dimethyl sulfoxide (DMSO) is one of the most controversial and misunderstood compounds in modern integrative medicine. First synthesized in the 19th century and widely studied in the mid-20th century, DMSO has been described as: A powerful anti-inflammatory agent A membrane-penetrating solvent A free-radical scavenger A cryoprotective compound used in stem cell preservation A pharmaceutical carrier Despite decades of research, DMSO has only one FDA-approved medical indication in the United States: intravesical treatment of interstitial cystitis . 👉 FDA drug database: https://www.fda.gov/drugs 👉 Memorial Sloan Kettering Cancer Center (DMSO overview): https://www.mskcc.org/cancer-care/integrative-medicine/herbs/dimethyl-sulfoxide Outside of this approval, DMSO is used off-label by some integrative, naturopathic, and functional medicine practitioners for pain, inflammation, musculoskeletal injury, scar tissue modulation, and in some cases as an adjunctive therapy in cancer-support proto...

Interest in repurposed medications such as ivermectin and fenbendazole for cancer treatment has grown rapidly online. While social media and patient communities discuss these drugs enthusiastically, both are off-label and experimental in oncology . Neither is approved for cancer care by major regulatory or guideline bodies, including the U.S. Food and Drug Administration (FDA) . This flagship guide provides a neutral, evidence-aware  discussion of: The scientific landscape Regulatory status Physician perspectives How to approach doctors responsibly Key patient safety considerations Practical resources with direct URLs you can visit today Important: This article is informational and not medical advice. 🔎 1. Why Ivermectin and Fenbendazole Are Discussed in Cancer What Drug Repurposing Is Drug repurposing explores whether existing drugs might work for new diseases, such as cancer. It offers theoretical advantages: Known safety profiles for approved uses Faster potential development...